Shares of Martin Shkreli’s Former Company Surge on Limited Coronavirus-Drug Study

Shares of Humanigen Inc., a biotech company briefly run by disgraced pharmaceutical executive Martin Shkreli, jumped 30% on the over-the-counter market Monday on results from the first human study of its experimental coronavirus-related drug. The drugmaker is one of a bevy of biotech and pharmaceutical companies world-wide whose share prices have reacted sharply to developments related to the potential progress toward a Covid-19 vaccine or treatment. Such news has led to sharp moves even among big drug companies, contributing…

Source link

error: Content is protected !!